Our synthetic approach to cavicularin also focused on
the use of a DielsÀAlder cascade to form the nonplanar B
ring (Scheme 1). DielsÀAlder-retro-DielsÀAlder cascades
to build phenyl rings are well precedented,6 including the
elegant synthesis of the strained-ring alkaloid haouamine
by Baran and Burns.7 The regiochemistry of the DielsÀ
Alder addition must be controlled in the cyclization event,
because there are two regiochemical outcomes of the
cascade. Cavicularin displays a para-substituted B-ring,
which requires formation of a bond between C6 and C5
(cavicularin numbering). DielsÀAlder addition with the
undesired regiochemistry would give a meta-substituted
B-ring (vide infra). Intermolecular pyrone DielsÀAlder
reactions often give mixtures of regioisomeric products,8
and we suspected that the constraints of the molecular
architecture would not be sufficient to guarantee forma-
tion of the desired regioisomer in the DielsÀAlder event.
Accordingly, we planned to use an alkyne equivalent
functional group with suitable electronic bias to favor
formation of the desired regioisomer. Of the various
alkyne-equivalent functional groups for DielsÀAlder reac-
tions,9 a vinyl sulfone (3) was selected as a substrate. The
electronic bias of the sulfone was anticipated to induce the
desired bond formation between the electrophilic C5 atom
of the vinyl sulfone and the nucleophilic C6 atom of the
pyrone. Vinyl sulfones have been used as alkyne equiva-
lents in pyrone DielsÀAlder reactions.10 Intermediate 3
was envisioned to arise from differentially functionalized
dihydrophenanthrene 4.
Our initial attempt at the synthesis of 4 began with
benzaldehyde 5 (Scheme 2).11 Wittig olefination of 5 with
the ylide derived from known benzyl bromide 612 gave
substituted stilbene 7 as a single geometrical isomer. The
stereochemistry of the stilbene was assigned as Z based on
the coupling constant (3JHH = 8 Hz) ofthe vinylic protons.
Reduction of the alkene in the presence of the aryl bro-
mides was accomplished using in situ generated diimide to
yield dibromide 8.13
Scheme 2. First-Generation Dihydrophenanthrene Synthesis
Reductive cyclization of 8 using Stille or Ullman condi-
tions14 gave only trace amounts of the desired dihydrophen-
anthrene 9. Attempts to improve the yield of the intra-
molecular coupling were not successful. Cyclization of
Z-configured 7 using such conditions led to dehalogenation
of the starting material without formation of any detect-
able phenanthrene product. Similarly, Wurtz-type condi-
tions failed to advance either 7 or 8 to cyclized products.
The second-generation synthesis of dihydrophenan-
threne 4 builds on a related strategy reported by Castle
(Scheme 3).15 Isovanillin derivative 5 was olefinated to
produce bromostyrene 10. Intermediate 10 was trans-
formed into coupling partner 12 using standard condi-
tions. Suzuki coupling of boronic ester 12 and bromide 13
(prepared from the corresponding benzaldehyde16) led to
biphenyl 14. Ring-closing metathesis gave a phenanthrene,
which underwent partial reduction of the phenanthrene
and hydrogenolysis of the benzyl ether to produce the
corresponding phenol. Activation of the phenol as the
Scheme 1. Retrosynthetic Analysis of Cavicularin
(5) (a) Dam, J. H., Ph.D. Thesis, Technical University of Denmark,
2009. (b) Gulder, T.; Dam, J. H.; Baran, P. S. Abstracts of Papers, Western
Regional Meeting of the American Chemical Society, Las Vegas, NV,
Sept 23À27, 2008.
(6) Gulder, T.; Baran, P. S. Nat. Prod. Rep. 2012, 29, 899–934.
(7) Baran, P. S.; Burns, N. Z. J. Am. Chem. Soc. 2006, 128, 3908–
3909.
(12) (a) Berger, D. M.; Birnberg, G.; DeMorin, F.; Dutia, M.; Powell,
D.; Wang, Y. D. Synthesis 2003, 11, 1712–1716. (b) Fukuyama, Y.;
Yaso, H.; Mori, T.; Takahashi, H.; Minami, H.; Kodama, M. Hetero-
cycles 2001, 54, 259–274.
(13) (a) Marshall, J. A.; Gung, W. Y. Tetrahedron 1989, 45, 1043–
1052. (b) Dewey, R. S.; van Tamelen, E. E. J. Am. Chem. Soc. 1961, 83,
3729.
(14) For reviews, see: (a) Farina, V.; Krishnamurthy, V.; Scott, W. J.
Org. React. 1997, 50, 1–652. (b) Nelson, T. D.; Crouch, R. D. Org. React.
2004, 63, 265–555.
(15) Jones, S. B.; He, L.; Castle, S. L. Org. Lett. 2006, 8, 3757–3760.
(16) Kobayashi, S.; Okimoto, K.; Imakura, Y. Chem. Pharm. Bull.
1982, 30, 1567–1573.
(8) Woodard, B. T.; Posner, G. H. Adv. Cycloaddition 1999, 5, 47–83.
(9) For example: (a) Ono, N.; Kamimura, A.; Kaji, A. Tetrahedron
Lett. 1986, 27, 1595–1598. (b) Anderson, W. K.; Dewey, R. H. J. Am.
Chem. Soc. 1973, 95, 7161–7162. (c) Danishefsky, S.; Prisbylla, M. P.;
Hiner, S. J. Am. Chem. Soc. 1978, 100, 2918–2920.
(10) (a) Pindur, U.; ErfanianÀAbdoust, H. Liebigs Ann. Chem. 1989,
12, 1275–1276. (b) Pratt, A. J.; Rendle, P. M.; Steel, P. J. Aust. J. Chem.
2011, 64, 945–950.
(11) Prepared from 2-bromo-3-hydroxy-4-methoxybenzaldehyde:
(a) Hamann, P. R.; Toth, J. E.; Fuchs, P. L. J. Org. Chem. 1984, 49,
3865–3867. (b) Natarajan, S.; Rajeswari, S.; Chandrasekaran, S.; Pai,
B. R.; Shanmuganathan, S.; Rao, K. U. Ind. J. Chem. Sect. B: Org.
Chem. Incl. Med. Chem. 1982, 21, 95–97.
B
Org. Lett., Vol. XX, No. XX, XXXX